Cargando…

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

BACKGROUND: High probability of metastasis limited the long-term survival of patients with hepatocellular carcinoma (HCC). Our previous study revealed that Galectin-3 was closely associated with poor prognosis in HCC patients. METHODS: The effects of Galectin-3 on tumour metastasis were investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Mengjia, Pan, Qiuzhong, Yang, Jieying, He, Junyi, Zeng, Jianxiong, Cheng, Shaoyan, Huang, Yue, Zhou, Zi-Qi, Zhu, Qian, Yang, Chaopin, Han, Yulong, Tang, Yan, Chen, Hao, Weng, De-Sheng, Xia, Jian-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653936/ https://www.ncbi.nlm.nih.gov/pubmed/32801345 http://dx.doi.org/10.1038/s41416-020-1022-4

Ejemplares similares

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma
por: Song, Mengjia, et al.
Publicado: (2019)

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
por: Huang, Yue, et al.
Publicado: (2022)

SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway
por: Yang, Jieying, et al.
Publicado: (2022)

Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma
por: Yang, Jieying, et al.
Publicado: (2023)

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
por: Sun, Fengze, et al.
Publicado: (2021)

Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma
por: Yang, Chaopin, et al.
Publicado: (2023)

Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma
por: Pęksa, Rafał, et al.
Publicado: (2023)

BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma
por: Han, Yulong, et al.
Publicado: (2023)

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype
por: Li, Han, et al.
Publicado: (2022)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma
por: Setayesh, Tahereh, et al.
Publicado: (2020)

Case of Amaurosis from Metastasis, Terminating Favourably
por: Lessey, Thomas
Publicado: (1826)

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
por: Yang, Xinyi, et al.
Publicado: (2022)

The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma
por: Avnet, Sofia, et al.
Publicado: (2021)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Histone H3 activates caspase-1 and promotes proliferation and metastasis in hepatocellular carcinoma
por: Jing, Mengjia, et al.
Publicado: (2023)

Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma
por: Maftouh, Mina, et al.
Publicado: (2014)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer
por: Li, Changpeng, et al.
Publicado: (2023)

Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma
por: Wang, Mingchao, et al.
Publicado: (2017)

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
por: Song, Meng‐Jia, et al.
Publicado: (2021)

Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer
por: Song, Mengjia, et al.
Publicado: (2023)

Extracellular Galectin-3 in Tumor Progression and Metastasis
por: Fortuna-Costa, Anneliese, et al.
Publicado: (2014)

NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma
por: Ye, Yingnan, et al.
Publicado: (2016)

TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin
por: Yuan, Kefei, et al.
Publicado: (2019)

Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
por: Zhang, Ning, et al.
Publicado: (2014)

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours
por: Perlman, Elizabeth J., et al.
Publicado: (2015)

Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancer
por: He, Peirong, et al.
Publicado: (2016)

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence
por: Heydt, Q., et al.
Publicado: (2021)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Galectin-1 and Galectin-3 Mediate Protocadherin-24-Dependent Membrane Localization of β-catenin in Colon Cancer Cell Line HCT116
por: Ose, Rui, et al.
Publicado: (2012)

ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
por: Cui, Honglei, et al.
Publicado: (2021)

MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma
por: You, Yu, et al.
Publicado: (2016)

An Argument in Favour of Tobacco
Publicado: (1893)

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma
por: Chen, Baiyang, et al.
Publicado: (2022)

meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.
por: Berenbaum, M. C., et al.
Publicado: (1986)

Nitric oxide favours tumour-promoting inflammation through mitochondria-dependent and -independent actions on macrophages
por: Drehmer, Daiana, et al.
Publicado: (2022)

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma
por: Wang, Zhihui, et al.
Publicado: (2021)

Gefitinib for asymptomatic brain metastasis from advanced non‐small cell lung cancer: Report of a favourable outcome
por: Liu, Wen‐Yang, et al.
Publicado: (2016)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ntmvki1g97jvnepqprc2rrl1iq